Search Results - "Epstein JE"

Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes.

Authors: Ganeshan H Huang J Belmonte M et al.

Source: PloS one [PLoS One] 2025 Feb 13; Vol. 20 (2), pp. e0318098. Date of Electronic Publication: 2025 Feb 13 (Print Publication: 2025).

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Long lived liver-resident memory T cells of biased specificities for abundant sporozoite antigens drive malaria protection by radiation-attenuated sporozoite vaccination.

Authors: de Menezes, Maria N. Ge, Zhengyu Cozijnsen, Anton et al.

Source: PLoS Pathogens. 5/27/2025, Vol. 21 Issue 5, p1-29. 29p.

Liver stage P. falciparum antigens highly targeted by CD4⁺ T cells in malaria-exposed Ugandan children.

Authors: Acevedo, Gonzalo R. Samiee, Sophie S. Ilala, Mikias et al.

Source: PLoS Pathogens. 2/24/2025, Vol. 21 Issue 2, p1-20. 20p.

Mitigation of Malaria in Sub-Saharan Africa through Vaccination: A Budding Road Map for Global Malaria Eradication.

Authors: Alum, Esther Ugo Ainebyoona, Christine Egwu, Chinedu Ogbonnia et al.

Source: Ethiopian Journal of Health Sciences. May2025, Vol. 35 Issue 3, p205-217. 13p.

Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacy.

Authors: Kc N Church LWP Riyahi P et al.

Source: Frontiers in immunology [Front Immunol] 2022 Oct 25; Vol. 13, pp. 1006716. Date of Electronic Publication: 2022 Oct 25 (Print Publication: 2022).

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Successful insertion and expression of a tetracycline transactivator in Anopheles stephensi associated with increased egg production and decreased hatching rate.

Authors: Inbar, Ehud Samantray, Ishaan Alford, Robert T. et al.

Source: Parasites & Vectors. 10/28/2025, Vol. 18 Issue 1, p1-11. 11p.

Natural killer cell antibody‐dependent cellular cytotoxicity to Plasmodium falciparum is impacted by cellular phenotypes, erythrocyte polymorphisms, parasite diversity and intensity of transmission.

Authors: Tukwasibwe, Stephen Lewis, Savannah Nicole Taremwa, Yoweri et al.

Source: Clinical & Translational Immunology. 2024, Vol. 13 Issue 11, p1-16. 16p.

The exception that proves the rule: Virulence gene expression at the onset of Plasmodium falciparum blood stage infections.

Authors: Wichers-Misterek, Jan Stephan Krumkamp, Ralf Held, Jana et al.

Source: PLoS Pathogens. 6/29/2023, Vol. 18 Issue 6, p1-27. 27p.

Symptomatic malaria enhances protection from reinfection with homologous Plasmodium falciparum parasites.

Authors: Markwalter, Christine F. Petersen, Jens E. V. Zeno, Erica E. et al.

Source: PLoS Pathogens. 6/12/2023, Vol. 18 Issue 6, p1-18. 18p.

Distinct immune responses associated with vaccination status and protection outcomes after malaria challenge.

Authors: Oyong, Damian A. Duffy, Fergal J. Neal, Maxwell L. et al.

Source: PLoS Pathogens. 5/17/2023, Vol. 18 Issue 5, p1-28. 28p.

Safety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium falciparum malaria infection.

Authors: Berry, Andrea A. Richie, Thomas L. Church, L. W. Preston et al.

Source: Malaria Journal. 3/17/2025, Vol. 24 Issue 1, p1-13. 13p.

CD105-microvessel density analysis and its clinical value in urothelial carcinoma of bladder patients.

Authors: Siddhartha, Rohit Singhai, Atin Goel, Apul et al.

Source: Biomarkers. Feb2025, Vol. 30 Issue 1, p23-36. 14p.

A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.

Authors: Sklar MJ Maiolatesi S Patterson N et al.

Source: PloS one [PLoS One] 2021 Sep 08; Vol. 16 (9), pp. e0256980. Date of Electronic Publication: 2021 Sep 08 (Print Publication: 2021).

Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

IMRAS-Immunization with radiation-attenuated Plasmodium falciparum sporozoites by mosquito bite: Cellular immunity to sporozoites, CSP, AMA1, TRAP and CelTOS.

Authors: Sedegah M Hollingdale MR Ganeshan H et al.

Source: PloS one [PLoS One] 2021 Aug 20; Vol. 16 (8), pp. e0256396. Date of Electronic Publication: 2021 Aug 20 (Print Publication: 2021).

Publication Type: Clinical Trial, Phase I; Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One

Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response.

Authors: Kapulu, Melissa C. Kimani, Domtila Njuguna, Patricia et al.

Source: BMC Infectious Diseases. 1/24/2022, Vol. 22 Issue 1, p1-10. 10p.

Genetic diversity of Plasmodium falciparum and Plasmodium vivax field isolates from the Nowshera district of Pakistan.

Authors: Hayat, Chandni Kamil, Atif Khan, Asifullah et al.

Source: Malaria Journal. 11/25/2024, Vol. 23 Issue 1, p1-8. 8p.

Germinal center activity and B cell maturation are associated with protective antibody responses against Plasmodium pre-erythrocytic infection.

Authors: Visweswaran, Ganesh Ram R. Vijayan, Kamalakannan Chandrasekaran, Ramyavardhanee et al.

Source: PLoS Pathogens. 7/6/2022, Vol. 18 Issue 7, p1-24. 24p.

Safety, infectivity and immunogenicity of a genetically attenuated blood-stage malaria vaccine.

Authors: Webster, Rebecca Sekuloski, Silvana Odedra, Anand et al.

Source: BMC Medicine. 11/22/2021, Vol. 19 Issue 1, p1-13. 13p.

Intradermal Naked DNA Vaccination by DNA Tattooing for Mounting Tumor-Specific Immunity in Stage IV Melanoma Patients: A Phase I Clinical Trial.

Authors: Geukes Foppen, Marnix H. Rohaan, Maartje W. Borgers, Jessica S.W. et al.

Source: Oncology Research & Treatment. 2024, Vol. 47 Issue 7/8, p351-359. 9p.

Evaluation of naturally acquired immune responses against novel pre-erythrocytic Plasmodium vivax proteins in a low endemic malaria population located in the Peruvian Amazon Basin.

Authors: Ventocilla, Julio A. Tapia, L. Lorena Ponce, Reynaldo et al.

Source: Malaria Journal. 5/23/2024, Vol. 23 Issue 1, p1-15. 15p.